Cargando…
Direct Medical Costs of Advanced Breast Cancer Treatment: A Real-World Study in the Southeast of The Netherlands
OBJECTIVES: Policy makers increasingly seek to complement data from clinical trials with information from routine care. This study aims to provide a detailed account of the hospital resource use and associated costs of patients with advanced breast cancer in The Netherlands. METHODS: Data from 597 p...
Autores principales: | Schneider, Paul Peter, Ramaekers, Bram L., Pouwels, Xavier, Geurts, Sandra, Ibragimova, Khava, de Boer, Maaike, Vriens, Birgit, van de Wouw, Yes, den Boer, Marien, Pepels, Manon, Tjan-Heijnen, Vivianne, Joore, Manuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105643/ https://www.ncbi.nlm.nih.gov/pubmed/33933235 http://dx.doi.org/10.1016/j.jval.2020.12.007 |
Ejemplares similares
-
Variability of cost trajectories over the last year of life in patients with advanced breast cancer in the Netherlands
por: Schneider, Paul P., et al.
Publicado: (2020) -
Cost and cost-effectiveness of adjuvant trastuzumab in the real world setting: A study of the Southeast Netherlands Breast Cancer Consortium
por: Seferina, Shanly C., et al.
Publicado: (2017) -
Healthcare Use during the Last Six Months of Life in Patients with Advanced Breast Cancer
por: Schmitz, Renée. S. J. M., et al.
Publicado: (2021) -
Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry
por: Ibragimova, Khava I. E., et al.
Publicado: (2021) -
Quality of life in a real-world cohort of advanced breast cancer patients: a study of the SONABRE Registry
por: Claessens, Anouk K. M., et al.
Publicado: (2020)